Nasdaq:US$34.13 (+0.27) | HKEX:HK$55.35 (+0.35) | AIM:£5.14 (+0)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 3 Oct 2013

Analyst briefing on Chi-Med’s pharmaceutical R&D business on 9 October 2013